EU Medical Devices Regulation – Unique Device Identifier (UDI)
In 2017, two Regulations on medical devices (MDR) and in in vitro diagnostic medical devices (IVDR) entered into force in the European Union (EU), establishing a modernized and more robust EU legislative framework and safeguarding a better public health protection and patient safety. According to the these Regulations, the Unique Device Identifier (UDI) will be mandatory for all medical devices and in vitro medical devices.
Liliana Teles

Liliana Teles

Regulatory Affairs Manager


According to the new EU Medical Devices Regulation (MDR – Regulation (EU) 2017/745) and the In Vitro Diagnostic Medical Devices Regulation  (IVDR – Regulation (EU) 2017/746), the “Unique Device Identifier” (UDI) means a “series of numeric or alphanumeric characters that is created through internationally accepted device identification and coding standards and that allows unambiguous identification of specific devices on the market”.

The main goal of the UDI is to allow the identification and improve the traceability of devices. The UDI will also allow a better monitoring by the competent authorities as well as it represents a fighting mechanism against counterfeit medical devices.

The UDI will be mandatory for all medical devices and in vitro medical devices, except for the custom-made and performance study/investigational devices.

The UDI system is described in the Part C of Annex VI of both Regulations and consists of several parts:Production of an UDI:

  • UDI device identifier (‘UDI-DI’), which is specific to a manufacturer and a device;
  • UDI production identifier (‘UDI-PI’), which identifies the unit device production and the package devices (if applicable).
  • Placing the UDI on the label of the device or its packaging (specific requirements);
  • Storage of the UDI by economic operators, health institutions and health care professionals;
  • Establishment of an electronic system for Unique Device Identification (‘UDI database’).

The basic UDI-DI will be the access key for device-related information and therefore is referenced in relevant documentation (e.g., certificates, declaration of conformity, technical documentation). The basic UDI-DI has the objective of identifying (in a unique manner) and connect devices with the same intended purpose.

The label and all higher levels of packaging (not shipping containers) of medical devices must include the UDI information, including the UDI-DI and UDI-PI. In case of reusable devices, the UDI carrier shall be placed on the device itself (direct marking). The UDI-DI of the device should appear on the EU declaration of conformity.

An UDI shall be attributed to a medical device created before placing such device on the market. The manufacturer should ensure that all information required is correctly submitted to the UDI database (European Database on Medical Devices – EUDAMED). Moreover, the manufacture needs to keep up-to-date a list of all UDIs that is has assigned.

The UDI database, integrated with EUDAMED, should be set up and managed by the European Commission, in order to validate, collate, process and make available the information to the public (free of charge, with maximum accessibility).


The UDI assignment will be mandatory from 26th May 2021 for medical devices and from 26th May 2022 for in vitro diagnostic medical devices. When it comes to the submission of UDI data at EUDAMED database, it will be obligatory for medical devices from 26th November 2022 and from 26th November 2023 for in vitro diagnostic medical devices. Manufacturers may voluntarily comply with registration of their medical devices and in vitro medical devices from 26th May 2021 and 26th May 2022, respectively.

When it comes to the obligation of placing the UDI carrier, the timeline will be in accordance with the type of medical device (risk-based). UDI-carriers must be placed on the labels of class III devices by 26 May 2021 as long as for class I devices the timeline is 26 May 2025.

In sum, the manufacturer has the responsibility of assigning and register the UDI (and basic UDI-DI) and placing that information on the label and/or packaging. If a distributor, importer or other natural or legal person assumes the obligations incumbent on manufacturers, it also assumes all relevant responsibilities related to UDI (including labelling).

The UDI system can be complex and medical devices manufacturers must ensure compliance with the MDR and IVDR. Our team is here to assist your company throughout the entire process, turning it simpler and easier to make your medical device available on the EU market.


  1. Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices. Available at:
  2. Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices. Available at:
  3. MDCG 2019-4 . Timelines for registration of device data elements in EUDAMED. Available at:


cosmetic products

May Butylphenyl Methylpropional be used in Cosmetic Products?

Butylphenyl Methylpropional, also known as Lilial, is a fragrance ingredient that has been used for years in several cosmetic and non-cosmetic products. Nevertheless, some concerns have been expressed regarding the use of this ingredient and its risk to consumers. According to an amendment to the CLP Regulation, the use of Butylphenyl Methylpropional will be prohibited in cosmetic products from 1st March 2022.

Read More »
cosmetic products

How are Cosmetic Products Regulated in the United Arab Emirates?

The United Arab Emirates (UAE) are an emerging market for the beauty industry. Cosmetics and personal care products supplied or sold in the UAE must comply with the health and safety requirements set out in UAE legislation. Overall, the process for importing a cosmetic product into the UAE market from the European Union can be quite straightforward since the UAE has aligned several of its requirements with the European Cosmetic Regulation.

Read More »
cosmetic products

European Commission Report on Nanomaterials – 2021

The European Commission is required to submit to the European Parliament and the Council an annual status report on the use of nanomaterials in cosmetic products and to review the provisions concerning nanomaterials in the European Regulation (EC) No 1223/2009 on cosmetic products. In July 2021, the Commission has issued its latest annual report on this subject.

Read More »
cosmetic products

New Labelling Requirements for Cosmetic Products in China

The new Cosmetics Supervision and Administration Regulation (CSAR) was enacted in China. The National Medical Products Administration (NMPA) has released standards for the testing of cosmetic products’ safety profile and efficacy claims. The NMPA has also published the Administrative Measures on Cosmetics Labelling, an updated set of requirements for the label of cosmetic products made available in the Chinese market.

Read More »
cosmetic products

50th Amendment to the IFRA Code of Practice

On June 30, IFRA announced the notification of the 50th Amendment to the IFRA Standards. The Standards form the basis for the globally accepted and recognized risk management system for the safe use of fragrance ingredients and are part of the IFRA Code of Practice. The amendment introduced one update to the Standards and one new prohibited substance – Mintlacton.

Read More »
medical devices

EN ISO 13485:2016 – Amendment 11 has been published!

The European standardisation bodies CEN and CENELEC published EN ISO 13485:2016+A11:2021 featuring new annexes ZA and ZB that link the requirements of the MDR (Regulation EU 2017/745) and the IVDR (Regulation EU 2017/746), respectively, to specific clauses of the standard.

Read More »
cosmetic products

How are Cosmetic Products Regulated in India?

The different expectations and needs of consumers are continually changing and therefore the cosmetic industry needs to be gradually evolve to meet the new consumer’s demand. In this regard, India has recently introduced some regulatory updates to ensure that cosmetics placed on the market are safer for all consumers.

Read More »
cosmetic products

Is Phenoxyethanol Safe for Use in All Cosmetic Products?

Phenoxyethanol is a common preservative used in cosmetic and personal care products worldwide. It has been subject to various safety assessments and most concluded about its safety under the current most frequent uses. Nevertheless, some concerns were raised by the French Agency ANSM, particularly regarding its use in products intended for the nappy area in children up to 3 years old.

Read More »
cosmetic products

Cannabis-Derived Ingredients in Cosmetic Products

Cannabis-derived ingredients are popular compounds with interesting properties. There is specific EU and national legislation regarding cannabis-derived ingredients, identifying which extracts and derivatives may be used in cosmetic products. There are several aspects to consider to ensure compliance when adding these compounds to cosmetics and personal care products.

Read More »
cosmetic products

Cosmetic Products Testing in the European Union

A cosmetic product which is made available on the European Union market needs to prove that it is safe for consumers. Apart from the mandatory testing, depending on the claims to be used or the type of cosmetic product to be placed on the market, additional tests may be required.

Read More »

New EU Commission Recommendation for PPE and Medical Devices – COVID-19

PPE and Medical Devices have proven to be essential for healthcare workers in the efforts to contain the COVID-19 outbreak. In March 2020, the EU Commission urged the economic operators to increase rapid supply into the market. Currently, the Commission considers that the conditions for exceptional access to market are no longer met, limiting the placing of PPE and Medical Devices which have not successfully undergone the relevant conformity assessment procedures applicable on the EU market.

Read More »